share_log

Glucose Health, Inc. Fiscal 2021 Annual Report

Glucose Health, Inc. Fiscal 2021 Annual Report

葡萄糖健康公司2021財年年度報告
GlobeNewswire ·  2022/02/10 21:11

BENTONVILLE, AR, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial metrics presented in its Fiscal 2021 Annual Report posted today at OTCMarkets.com. In fiscal 2021, Glucose Health, Inc. more than doubled gross profits, effectively doubled revenue, and achieved the unique status of a debt free, emerging growth, company.

亞洲網阿肯色州本頓維爾2022年2月10日電葡萄糖健康公司(場外交易代碼:GLUC)(簡稱“公司”)高興地強調其2021財年年度報告中介紹的部分財務指標,該報告今天公佈在場外交易市場(OTCMarkets.com)上。在2021財年,葡萄糖健康公司的毛利潤翻了一番多,收入實際上翻了一番,並取得了無債務、新興成長型公司的獨特地位。

  • Fiscal 2021 Revenue of $953,681 vs. $480,713 for Fiscal 2020 = a 98% increase.
  • Fiscal 2021 Gross Profit of $410,042 vs. $173,545 for Fiscal 2020 = a 136% increase.
  • Fiscal 2021 Total Liabilities of $9,554 vs. $380,652 for Fiscal 2020
  • 2021財年收入為953,681美元,2020財年為480,713美元=增長98%。
  • 2021財年毛利潤為410,042美元,而2020財年為173,545美元=增長136%。
  • 2021財年總負債為9,554美元,2020財年為380,652美元

During fiscal 2021, Glucose Health, Inc. introduced four new GLUCODOWN® Diabetic Friendly, Blood Sugar Maintenance "enhanced water" flavors, complementing its existing four GLUCODOWN® iced tea flavors, launched in the fourth quarter of 2017.  New GLUCODOWN® Cherry, in particular, outsold each of the three "enhanced water" flavors and also outsold all four established iced tea flavors, at Amazon. Within weeks, GLUCODOWN® Cherry sold out of its entire initial production run, at Amazon.

在2021財年,葡萄糖健康公司推出了四種新的GLUCODOWN®糖尿病友好型血糖維持“增強型水”口味,補充了其於2017年第四季度推出的現有四種GLUCODOWN®冰茶口味。特別是新的GLUCODOWN®櫻桃,在亞馬遜的銷量超過了三種“強化水”口味,也超過了所有四種現有的冰茶口味。在幾周內,GLUCODOWN®Cherry在亞馬遜的整個初始生產過程中就銷售一空。

For fiscal 2022, the Company will build upon its success at Amazon and significantly ramp up sales and marketing partnerships to expand distribution of GLUCODOWN® with new brick-and-mortar retailers. Additionally, in fiscal 2022, Glucose Health, Inc. will launch an innovative new brand; a ready-to-drink, delicious and healthy beverage, specifically formulated to address the nutritional needs of the under-served 45+ consumer.

在2022財年,該公司將在亞馬遜取得成功的基礎上,大力加強銷售和營銷合作伙伴關係,以擴大GLUCODOWN®與新的實體零售商的分銷。此外,在2022財年,葡萄糖健康公司將推出一個創新的新品牌,這是一種即飲、美味和健康的飲料,專門為滿足服務不足的45歲以上消費者的營養需求而配製。

About Glucose Health, Inc. (OTC: GLUC)

葡萄糖健康公司簡介(場外交易代碼:GLUC)

Manufactured by Glucose Health, Inc., the GLUCODOWN® brand is defining a new beverage industry category – functional, diabetic friendly, beverages. By specializing in producing healthy and delicious beverages, nutritionally appropriate1 for the nation's 100+ million2 pre and Type-2 diabetics, and additionally in 2022, launching a new healthy and delicious ready-to-drink beverage formulated to meet the nutritional needs of 45+ consumers, Glucose Health, Inc. is uniquely positioned among all emerging beverage companies in America. Glucose Health, Inc. is a publicly traded company with the ticker symbol OTC: GLUC.

由葡萄糖健康公司生產的GLUCODOWN®品牌正在定義一個新的飲料行業類別-功能性、糖尿病友好型飲料。通過專業生產健康美味的飲料、營養適中的飲料、滿足全國1億以上2型糖尿病患者的營養需求,並在2022年推出一種新的健康美味即飲飲料,以滿足45+消費者的營養需求,葡萄糖健康公司在美國所有新興飲料公司中處於獨特的地位。葡萄糖健康公司是一家上市公司,股票代碼為OTC:GLUC。

For more GLUC news visit 
Like us on Facebook at 

有關更多GLUC新聞,請訪問
在Facebook上點讚我們

1 For citations visit 
National Diabetes Statistics Review, 2020; Centers for Disease Control and Prevention, Department of Health and Human Services

1用於引用訪問2 2020年全國糖尿病統計評論衞生與公眾服務部疾病控制和預防中心

Contact:
Murray Fleming
Glucose Health, Inc.
info@glucosehealthinc.com
(479) 802-3827

聯繫方式:
默裏·弗萊明
葡萄糖健康公司
電子郵箱:info@graoseHealth Thinc.com(479) 802-3827

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and while Glucose Health, Inc. is not subject to the 1934 Securities and Exchange Act, contains forward-looking statements within the meaning Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects," "anticipates," "intends," "estimates," "plans," "potential, "possible," "probable, "believes," "seeks," "may, "will, "should," "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.

本新聞稿包含符合1933年“證券法”(經修訂)第27A條的前瞻性陳述,雖然葡萄糖健康公司不受1934年“證券交易法”的約束,但含有符合1934年“證券交易法”第21E條(經修訂)的前瞻性陳述。不描述歷史事實的陳述構成前瞻性陳述,經常但並非總是通過使用“預期”、“預期”、“打算”、“估計”、“計劃”、“可能”、“相信”、“尋求”、“可能”、“將會”、“應該”、“可能”或此類術語的否定或其他類似表述來識別。由於公司業務固有的風險和不確定性,實際結果可能與本新聞稿中陳述的大不相同。告誡讀者不要過度依賴這些前瞻性陳述,這些陳述僅説明截至本文發佈之日的情況。所有前瞻性陳述都完全受本警告性聲明的限制,公司沒有義務修改或更新本新聞稿,以反映此後發生的事件或情況。


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論